Shell Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,862
| Closed | -$281K | – | 1433 |
|
|
2022
Q3 | $281K | Sell |
1,862
-486
| -21% | -$73.3K | 0.01% | 862 |
|
|
2022
Q2 | $342K | Buy |
2,348
+4
| +0.2% | +$583 | 0.01% | 918 |
|
|
2022
Q1 | $278K | Sell |
2,344
-346
| -13% | -$41K | 0.01% | 1065 |
|
|
2021
Q4 | $371K | Buy |
2,690
+19
| +0.7% | +$2.62K | 0.01% | 1026 |
|
|
2021
Q3 | $371K | Sell |
2,671
-110
| -4% | -$15.3K | 0.01% | 996 |
|
|
2021
Q2 | $270K | Buy |
2,781
+150
| +6% | +$14.6K | 0.01% | 1149 |
|
|
2021
Q1 | $180K | Sell |
2,631
-1,992
| -43% | -$136K | ﹤0.01% | 1173 |
|
|
2020
Q4 | $396K | Hold |
4,623
| – | – | 0.01% | 895 |
|
|
2020
Q3 | $301K | Hold |
4,623
| – | – | 0.01% | 904 |
|
|
2020
Q2 | $338K | Sell |
4,623
-83
| -2% | -$6.07K | 0.01% | 836 |
|
|
2020
Q1 | $160K | Sell |
4,706
-71
| -1% | -$2.41K | ﹤0.01% | 1057 |
|
|
2019
Q4 | $260K | Sell |
4,777
-134
| -3% | -$7.29K | 0.01% | 1081 |
|
|
2019
Q3 | $205K | Sell |
4,911
-42
| -0.8% | -$1.75K | ﹤0.01% | 1129 |
|
|
2019
Q2 | $217K | Sell |
4,953
-112
| -2% | -$4.91K | ﹤0.01% | 1115 |
|
|
2019
Q1 | $261K | Hold |
5,065
| – | – | 0.01% | 1063 |
|
|
2018
Q4 | $187K | Sell |
5,065
-400
| -7% | -$14.8K | ﹤0.01% | 1046 |
|
|
2018
Q3 | $205K | Buy |
+5,465
| New | +$205K | ﹤0.01% | 1099 |
|